|
See Category: Congenital malformations, deformations and chromosomal abnormalities
ICD-10 (CM) Code and Descriptor
Q06.1 |
Hypoplasia and dysplasia of spinal cord
|
Q061 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
17.76%
|
18.69%
|
14.95%
|
10.28%
|
14.02%
|
6.54%
|
8.41%
|
1.87%
|
2.80%
|
0.93%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Q06.1*:
CPT |
Description |
Number of Claims |
Sum Performed |
Q0162
|
ONDANSETRON ORAL |
23
|
368
|
J9025
|
AZACITIDINE INJECTION |
23
|
2,054
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
13
|
16
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
9
|
13
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
7
|
7
|
J8540
|
ORAL DEXAMETHASONE |
6
|
18
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6
|
6
|
80053
|
COMPREHEN METABOLIC PANEL |
5
|
5
|
G0467
|
FQHC VISIT, ESTAB PT |
4
|
4
|
84443
|
ASSAY THYROID STIM HORMONE |
3
|
3
|
99213
|
OFFICE O/P EST LOW 20 MIN |
3
|
3
|
99214
|
OFFICE O/P EST MOD 30 MIN |
3
|
3
|
80048
|
METABOLIC PANEL TOTAL CA |
3
|
3
|
97530
|
THERAPEUTIC ACTIVITIES |
2
|
5
|
82607
|
VITAMIN B-12 |
2
|
2
|
82728
|
ASSAY OF FERRITIN |
2
|
2
|
82746
|
ASSAY OF FOLIC ACID SERUM |
2
|
2
|
83540
|
ASSAY OF IRON |
2
|
2
|
83550
|
IRON BINDING TEST |
2
|
2
|
36430
|
TRANSFUSION BLD/BLD COMPNT |
2
|
2
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Q06.1 related to the following DRG Codes:
091-093 791 793
|